Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rubius Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rubius Therapeutics Inc market cap is $5.15M.
What is the 52-week high for Rubius Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rubius Therapeutics Inc 52 week high is $0.3763 as of September 09, 2025.
What is the 52-week low for Rubius Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rubius Therapeutics Inc 52 week low is $0.0032 as of September 09, 2025.
What is Rubius Therapeutics Inc stock price today?
Rubius Therapeutics Inc stock price today is $0.057.
What was Rubius Therapeutics Inc stock price yesterday?
Rubius Therapeutics Inc stock price yesterday was $0.0555.
What is the PE ratio of Rubius Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rubius Therapeutics Inc’s P/E ratio is -0.03.
What is the Price-to-Book ratio of Rubius Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rubius Therapeutics Inc P/B ratio is 0.3405.
What is the 50-day moving average of Rubius Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rubius Therapeutics Inc 50-day moving average is $0.0217.